The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
The role of inflammation in schizophrenia
Open accessAbstract
High levels of pro-inflammatory substances such as cytokines have been described in the blood and cerebrospinal fluid of schizophrenia patients. Animal models of schizophrenia show that under certain conditions an immune disturbance during early life, such as an infection-triggered immune activation, might trigger lifelong increased immune reactivity. A large epidemiological study clearly demonstrated that severe infections and autoimmune disorders are risk factors for schizophrenia. Genetic studies have shown a strong signal for schizophrenia on chromosome 6p22.1, in a region related to the human leucocyte antigen (HLA) system and other immune functions. Another line of evidence demonstrates that chronic (dis)stress is associated with immune activation. The vulnerability-stress-inflammation model of schizophrenia includes the contribution of stress on the basis of increased genetic vulnerability for the pathogenesis of schizophrenia, because stress may increase pro-inflammatory cytokines and even contribute to a lasting pro-inflammatory state. Immune alterations influence the dopaminergic, serotonergic, noradrenergic, and glutamatergic neurotransmission. The activated immune system in turn activates the enzyme indoleamine 2,3-dioxygenase (IDO) of the tryptophan/kynurenine metabolism which influences the serotonergic and glutamatergic neurotransmission via neuroactive metabolites such as kynurenic acid. The described loss of central nervous system volume and the activation of microglia, both of which have been clearly demonstrated in neuroimaging studies of schizophrenia patients, match the assumption of a (low level) inflammatory neurotoxic process. Further support for the inflammatory hypothesis comes from the therapeutic benefit of anti-inflammatory medication. Metaanalyses have shown an advantageous effect of cyclo-oxygenase-2 inhibitors in early stages of schizophrenia. Moreover, intrinsic anti-inflammatory, and immunomodulatory effects of antipsychotic drugs are known since a long time. Anti-inflammatory effects of antipsychotics, therapeutic effects of anti-inflammtory compounds, genetic, biochemical, and immunological findings point to a major role of inflammation in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vulnerability: A new view of schizophrenia.
Zubin, J., & Spring, B. (1977) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.86.2.103 · Cited by 1,992
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.774 · Cited by 1,053
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., & Perry, V. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2614-05.2005 · Cited by 768
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
Immunity and immunopathology to viruses: what decides the outcome?
Rouse, B. T., & Sehrawat, S. (2010) · Nature Reviews Immunology · doi:10.1038/nri2802 · Cited by 619
Increased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030516 · Cited by 582
van Berckel, B. N., Bossong, M. G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.025 · Cited by 582
Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Doorduin, J., de Vries, E. F. J., Willemsen, A. T. M., de Groot, J. C., Dierckx, R. A., & Klein, H. C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066647 · Cited by 559
Maternal Infections and Subsequent Psychosis Among Offspring
Buka, S. L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.1032 · Cited by 510
Maternal Exposure to Toxoplasmosis and Risk of Schizophrenia in Adult Offspring
Brown, A. S., Schaefer, C. A., Quesenberry, C. P., Liu, L., Babulas, V. P., & Susser, E. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.767 · Cited by 496
Zhou, D., Kusnecov, A. W., Shurin, M. R., DePaoli, M., & Rabin, B. S. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243274 · Cited by 494
Elevated Maternal Interleukin-8 Levels and Risk of Schizophrenia in Adult Offspring
Brown, A. S., Hooton, J., Schaefer, C. A., Zhang, H., Petkova, E., Babulas, V., Perrin, M., Gorman, J. M., & Susser, E. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.889 · Cited by 489
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L. H., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 471
Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections.
Nikolich-Žugich, J. (2008) · Nature reviews. Immunology · doi:10.1038/nri2318 · Cited by 463 · cited 2×
“As in other sites of the body, inflammation in the central nervous system (CNS) has a dual role, i.e., it may be neuroprotective or neurotoxic (Hohlfeld et al., 2007).”
BackgroundGiovanoli, S., Engler, H., Engler, A., Richetto, J., Voget, M., Willi, R., Winter, C., Riva, M. A., Mortensen, P. B., Feldon, J., et al. (2013) · Science · doi:10.1126/science.1228261 · Cited by 459
Nair, A., & Bonneau, R. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.012 · Cited by 392
Levkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387 · cited 1×
“The improvement of cognition by minocycline has been described in animal models of schizophrenia (Mizoguchi et al., 2008) and in two double-blind, placebo-controlled add-on therapy trials in schizophrenia patients (Levkovitz et al., 2010; Chaudhry et al., 2012).”
BackgroundSteiner, J., Walter, M., Glanz, W., Sarnyai, Z., Bernstein, H.-G., Vielhaber, S., Kästner, A., Skalej, M., Jordan, W., Schiltz, K., et al. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.86 · Cited by 380
Viruses, schizophrenia, and bipolar disorder
Yolken, R. H., & Torrey, E. F. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.1.131 · Cited by 356
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Sommer, I. E., van Westrhenen, R., Begemann, M. J. H., de Witte, L. D., Leucht, S., & Kahn, R. S. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt139 · Cited by 342
Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or Stress
Sparkman, N. L., & Johnson, R. W. (2008) · Neuroimmunomodulation · doi:10.1159/000156474 · Cited by 332
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Linderholm, K. R., Skogh, E., Olsson, S. K., Dahl, M.-L., Holtze, M., Engberg, G., Samuelsson, M., & Erhardt, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq086 · Cited by 325
Cytokines, stress and depressive illness: Brain-immune interactions.
Anisman, H., & Merali, Z. (2003) · Annals of Medicine · doi:10.1080/07853890310004075 · Cited by 302
Differentiation of Mesencephalic Progenitor Cells into Dopaminergic Neurons by Cytokines
Ling, Z. D., Potter, E. D., Lipton, J. W., & Carvey, P. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6715 · Cited by 295
The Role of Immune System in Schizophrenia
Muller, N., & J. Schwarz, M. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823673 · Cited by 291
Chaudhry, I. B., Hallak, J., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S., Dunn, G., & Deakin, B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 279
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis
Hanson, D. R., & Gottesman, I. I. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-7 · Cited by 276
Laan, W., Grobbee, D. E., Selten, J.-P., Heijnen, C. J., Kahn, R. S., & Burger, H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05117yel · Cited by 264
Association Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia
Sorensen, H. J., Mortensen, E. L., Reinisch, J. M., & Mednick, S. A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn121 · Cited by 261
Meyer, U., Schwarz, M. J., & Müller, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.003 · Cited by 258
Self-citationImpaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Sathyasaikumar, K. V., Stachowski, E. K., Wonodi, I., Roberts, R. C., Rassoulpour, A., McMahon, R. P., & Schwarcz, R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq112 · Cited by 253
Müller, N., Krause, D., Dehning, S., Musil, R., Schennach-Wolff, R., Obermeier, M., Möller, H.-J., Klauss, V., Schwarz, M. J., & Riedel, M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.04.015 · Cited by 250
Self-citationDalman, C., Allebeck, P., Gunnell, D., Harrison, G., Kristensson, K., Lewis, G., Lofving, S., Rasmussen, F., Wicks, S., & Karlsson, H. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050740 · Cited by 247
Winter, C., Djodari-Irani, A., Sohr, R., Morgenstern, R., Feldon, J., Juckel, G., & Meyer, U. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009206 · Cited by 242 · cited 1×
“Maternal immune stimulation during pregnancy was shown to increase the number of mesencephalic dopaminergic neurons in the fetal brain (Winter et al., 2009); the increase was probably associated with a dopaminergic excess in the midbrain (Winter et al., 2009).”
BackgroundMaternal Exposure to Herpes Simplex Virus and Risk of Psychosis Among Adult Offspring
Buka, S. L., Cannon, T. D., Torrey, E. F., & Yolken, R. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.022 · Cited by 233
Prenatal Exposure to Maternal Genital and Reproductive Infections and Adult Schizophrenia
Babulas, V., Factor-Litvak, P., Goetz, R., Schaefer, C. A., & Brown, A. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.927 · Cited by 233
Antibodies to infectious agents in individuals with recent onset schizophrenia
Leweke, F. M., Gerth, C. W., Koethe, D., Klosterk�tter, J., Ruslanova, I., Krivogorsky, B., Torrey, E. F., & Yolken, R. H. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0481-6 · Cited by 226
Ellman, L. M., Deicken, R. F., Vinogradov, S., Kremen, W. S., Poole, J. H., Kern, D. M., Tsai, W. Y., Schaefer, C. A., & Brown, A. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.014 · Cited by 225
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
Godbout, J. P., & Johnson, R. W. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.007 · Cited by 224
Nonaffective Psychosis After Prenatal Exposure to Rubella
Brown, A. S., Cohen, P., Greenwald, S., & Susser, E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.438 · Cited by 219
Nitta, M., Kishimoto, T., Müller, N., Weiser, M., Davidson, M., Kane, J. M., & Correll, C. U. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt070 · Cited by 204
Self-citationAutoimmune diseases and infections as risk factors for schizophrenia
Benros, M. E., Mortensen, P. B., & Eaton, W. W. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06638.x · Cited by 186
Sommer, I. E., de Witte, L., Begemann, M., & Kahn, R. S. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06823 · Cited by 182
Neuro-immune crosstalk in CNS diseases
Kerschensteiner, M., Meinl, E., & Hohlfeld, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.009 · Cited by 179
Takano, A., Arakawa, R., Ito, H., Tateno, A., Takahashi, H., Matsumoto, R., Okubo, Y., & Suhara, T. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000313 · Cited by 175
Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms
Pearce, B. D. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000956 · Cited by 171
Versijpt, J. J., Dumont, F., van Laere, K. J., Decoo, D., Santens, P., Audenaert, K., Achten, E., Slegers, G., Dierckx, R., & Korf, J. (2003) · European Neurology · doi:10.1159/000070857 · Cited by 166
Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro
Jarskog, L. F., Xiao, H., Wilkie, M. B., Lauder, J. M., & Gilmore, J. H. (1997) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(97)00029-4 · Cited by 163
Placebo Response in Antipsychotic Clinical Trials: A Meta-analysis
Rutherford, B. R., Pott, E., Tandler, J. M., Wall, M. M., Roose, S. P., & Lieberman, J. A. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1319 · Cited by 160
The Psychiatric Symptoms of Rheumatic Fever
Mercadante, M. T., Busatto, G. F., Lombroso, P. J., Prado, L., Rosário-Campos, M. C., do Valle, R., Marques-Dias, M. J., Kiss, M. H., Leckman, J. F., & Miguel, E. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.2036 · Cited by 159
Anderson, G., Berk, M., Dodd, S., Bechter, K., Altamura, A. C., Dell’Osso, B. M., Kanba, S., Monji, A., Fatemi, S. H., Buckley, P. F., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.008 · Cited by 149
Self-citationDuration of illness and treatment effects on hippocampal volume in male patients with schizophrenia
Chakos, M., Schobel, S., Gu, H., Gerig, G., Bradford, D. W., Charles, C. H., & Lieberman, J. A. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.1.26 · Cited by 149
Diagnosis and pathogenesis of CNS lupus
van Dam, A. P. (1991) · Rheumatology International · doi:10.1007/bf00290244 · Cited by 141
Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons
Potter, E. D., Ling, Z. D., & Carvey, P. M. (1999) · Cell and Tissue Research · doi:10.1007/s004410051285 · Cited by 140
Clinical effects of COX?2 inhibitors on cognition in schizophrenia
M�ller, N., Riedel, M. J., Schwarz, M., & Engel, R. R. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0548-4 · Cited by 135
Self-citationExposure to Prenatal and Childhood Infections and the Risk of Schizophrenia
Westergaard, T., Mortensen, P. B., Pedersen, C. B., Wohlfahrt, J., & Melbye, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.993 · Cited by 133
Dual role of inflammation in CNS disease
Hohlfeld, R., Kerschensteiner, M., & Meinl, E. (2007) · Neurology · doi:10.1212/01.wnl.0000275234.43506.9b · Cited by 127
Gogtay, N., Lu, A., Leow, A. D., Klunder, A. D., Lee, A. D., Chavez, A., Greenstein, D., Giedd, J. N., Toga, A. W., Rapoport, J. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806485105 · Cited by 125
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
Müller, N. (2010) · PubMed · Cited by 122
Self-citationImbalanced Kynurenine Pathway in Schizophrenia
Kegel, M. E., Bhat, M., Skogh, E., Samuelsson, M., Lundberg, K., Dahl, M., Sellgren, C. M., Schwieler, L., Engberg, G., Schuppe‐Koistinen, I., et al. (2014) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s16800 · Cited by 122
Meyer, U., & Feldon, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1504-9 · Cited by 119
The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view
Müller, N., & Schwarz, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_33 · Cited by 117
Self-citationMyint, A.-M., Schwarz, M., Verkerk, R. M., Mueller, H. H., Zach, J., Scharpé, S., Steinbusch, H. W. M., Leonard, B. E., & Kim, Y. K. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.005 · Cited by 116
Self-citationMeisenzahl, E. M., Rujescu, D., Kirner, A., Giegling, I., Kathmann, N., Leinsinger, G. L., Maag, K. P., Hegerl, U., Hahn, K. M., & Möller, H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1316 · Cited by 111
Maternal infection during pregnancy and schizophrenia
Boksa, P. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0818 · Cited by 106
Condray, R., Dougherty, G. G., Keshavan, M. S., Reddy, R. D., Haas, G. L., Montrose, D. M., Matson, W. R., McEvoy, J. P., Kaddurah‐Daouk, R., & Yao, J. K. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001689 · Cited by 105
Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice
Mizoguchi, H., Takuma, K., Fukakusa, A., Ito, Y., Nakatani, A., Ibi, D., Kim, H., & Yamada, K. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0955-0 · Cited by 97
Meinl, E., Krumbholz, M., Derfuss, T. J., Junker, A., & Hohlfeld, R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.032 · Cited by 96
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects
Muller, N., Myint, A.-M., & J. Schwarz, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049552 · Cited by 94 · cited 1×
“A predominant type 2 immune response inhibits the enzyme indoleamine 2,3-dioxygenase (IDO), resulting in an increased production of kynurenic acid in schizophrenia and in NMDA receptor antagonism (Müller and Schwarz, 2007; Müller et al., 2011).”
BackgroundSelf-citationGrey matter changes can improve the prediction of schizophrenia in subjects at high risk
Job, D. E., Whalley, H. C., McIntosh, A. M., Owens, D. G. C., Johnstone, E. C., & Lawrie, S. M. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-29 · Cited by 93
Notarangelo, F. M., Wilson, E. H., Horning, K. J., Thomas, M. A. R., Harris, T. H., Fang, Q., Hunter, C. A., & Schwarcz, R. M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.011 · Cited by 91
Müller, N. (2014) · NeuroImmunoModulation · doi:10.1159/000356538 · Cited by 89
Self-citationKörschenhausen, D. A., Hampel, H. J., Ackenheil, M., Penning, R., & Müller, N. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00073-9 · Cited by 86
Self-citationVincent, A. C., & Bien, C. G. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70225-4 · Cited by 85
The Risk for Schizophrenia From Childhood and Adult Infections
Brown, A. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07101637 · Cited by 78
Neuroimmune–endocrine crosstalk in schizophrenia and mood disorders
Müller, N., & Schwarz, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.1017 · Cited by 76
Self-citationThe association of infectious agents and schizophrenia
Krause, D., Matz, J., Weidinger, E., Wagner, J., Wildenauer, A., Obermeier, M., Riedel, M. J., & Müller, N. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003653246 · Cited by 74
Self-citationChronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain
Ceresoli‐Borroni, G., Rassoulpour, A., Wu, H., Guidetti, P., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0432-z · Cited by 72
How Frustration Leads to Inflammation
O'Neill, L. A. J. (2008) · Science · doi:10.1126/science.1158398 · Cited by 65
Claes, S., Myint, A.-M., Domschke, K., Del-Favero, J., Entrich, K., Engelborghs, S., De Deyn, P., Mueller, N., Baune, B., & Rothermundt, M. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.03.012 · Cited by 65
Hayley, S. P., Wall, P. M., & Anisman, H. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01936.x · Cited by 64
Olsson, S. K., Andersson, A., Linderholm, K. R., Holtze, M., Nilsson-Todd, L. K., Schwieler, L., Olsson, E., Larsson, K., Engberg, G., & Erhardt, S. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009383 · Cited by 60
Childhood meningitis, brain maturation and the risk of psychosis*
Gattaz, W. F., Abrah�o, A. L., & Foccacia, R. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0431-3 · Cited by 54
Administration of Interleukin‐1 at Birth Affects Dopaminergic Neurons in Adult Mice a
Kabiersch, A., Furukawa, H., del Rey, A., & Besedovsky, H. O. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09556.x · Cited by 50
Perry, V. H. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.08.004 · Cited by 50
Herpes simplex type 2 virus encephalitis presenting as psychosis
Oommen, K. J., Johnson, P. C., & Ray, C. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90751-3 · Cited by 44
Wildenauer, D. B., Körschenhausen, D. A., Hoechtlen, W., Ackenheil, M., Kehl, M., & Lottspeich, F. (1991) · Electrophoresis · doi:10.1002/elps.1150120706 · Cited by 41
Possible anti-catatonic effects of minocycline in patients with schizophrenia
Ahuja, N., & Carroll, B. T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.01.018 · Cited by 41
Drug development in schizophrenia: are glutamatergic targets still worth aiming at?
GOFF, D. C. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000152 · Cited by 41
Adjunctive Recombinant Human Interferon Gamma-1b for Treatment-Resistant Schizophrenia in 2 Patients
Grüber, L., Bunse, T., Weidinger, E., Reichard, H., & Müller, N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14l09005 · Cited by 38
Self-citationMüller, N., & Bechter, K. (2013) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2013.04.004 · Cited by 37
Self-citationPsychiatric disorders in the encephalitic form of multiple sclerosis
Felgenhauer, K. (1990) · Journal of Neurology · doi:10.1007/bf00319661 · Cited by 36 · cited 1×
“For example, symptoms of schizophrenia have been described in the encephalitic form ofMS (Felgenhauer, 1990), in viral CNS infection with herpes simplex virus type 1 (HSV-1; Chiveri et al., 2003), HSV-2 (Oommen et al., 1982), and measles (Hiroshi et al., 2003) and also in autoimmune processes such…”
BackgroundMüller, N., von Gizycki-Nienhaus, B., Günther, W., & Meurer, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90160-2 · Cited by 34
Self-citationPsychosis following acute Sydenham’s chorea
Teixeira, A. L., Maia, D. P., & Cardoso, F. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0566-z · Cited by 33
Interleukin‐1, but Not Stress, Stimulates Glucocorticoid Output during Early Postnatal Life in Micea
Furukawa, H., del Rey, A., MONGE‐ARDITI, G., & Besedovsky, H. O. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09555.x · Cited by 33
Stress, Schizophrenia and Bipolar Disorder
Green, M. J., Girshkin, L., Teroganova, N., & Quidé, Y. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_290 · Cited by 29
Genius, J., Geiger, J., Dölzer, A.-L., Benninghoff, J., Giegling, I., Hartmann, A. M., Möller, H., & Rujescu, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059395 · Cited by 29
Kerbeshian, J., Burd, L., & Tait, A. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970601182652 · Cited by 17
Therapieresistente Depression mit Fatigue
Bechter, K., Bindl, A., Horn, M., & Schreiner, V. (2006) · Der Nervenarzt · doi:10.1007/s00115-006-2178-8 · Cited by 16
Schizophreniform Disorder with Cerebrospinal Fluid PCR Positivity for Herpes Simplex Virus Type 1
Chiveri, L., Sciacco, M., & Prelle, A. C. (2003) · European Neurology · doi:10.1159/000073062 · Cited by 14
Cerebral involvement of scleroderma presenting as schizophrenia-like psychosis
Müller, N., von Gizycki-Nienhaus, B., Botschev, C., & Meurer, M. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90054-m · Cited by 14
Self-citation[An adult case suspected of recurrent measles encephalitis with psychiatric symptoms].
Hiroshi, H., Seiji, K., Toshihiro, K., & Nobuo, K. (2003) · PubMed · Cited by 12
Cited by
Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects
Kim, H.-J., Cho, M.-H., Shim, W. H., Kim, J. K., Jeon, E.-Y., Kim, D.-H., & Yoon, S.-Y. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.103 · Cited by 475
Treatment resistance in psychiatry: state of the art and new directions
Howes, O. D., Thase, M. E., & Pillinger, T. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01200-3 · Cited by 413
Pollak, T. A., Lennox, B. R., Müller, S., Benros, M. E., Prüss, H., Tebartz van Elst, L., Klein, H., Steiner, J., Frodl, T., Bogerts, B., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30290-1 · Cited by 402
Wang, A. K., & Miller, B. J. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx035 · Cited by 389
Bryois, J., Skene, N. G., Hansen, T. F., Kogelman, L. J. A., Watson, H. J., Liu, Z., Eating Disorders Working Group of the Psychiatric Genomics Consortium, Adan, R., Alfredsson, L., Ando, T., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0610-9 · Cited by 366
Metadata
- Authors
- Müller, N., Weidinger, E., Leitner, B., & Schwarz, M. J.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2015-10-21
- Volume
- 9
- Pages
- 372-372
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2098234649
- Cited by
- 465
- References
- 112
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.